Home › NDC Lookup › RxCUI directory › RxCUI 2054227

500 ML albumin human-kjda 50 MG/ML Injection [Albuminex] — RxCUI 2054227

RxNorm drug concept · Semantic branded drug
RxCUI 2054227 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2054227
Official name500 ML albumin human-kjda 50 MG/ML Injection [Albuminex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAlbuminex 5 % per 500 ML Injection; ALBUMINEX 5 % in 500 ML Injection; Albuminex 50 MG/ML per 500 ML Injection
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 500 ML albumin human-kjda 50 MG/ML Injection [Al... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 500 ML albumin human-kjda 50 MG/ML Injection [Albuminex] RxCUI 2054227

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Albumin human, USP 828529
    • Albumin human-kjda 2054166
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Albuminex 2054160
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Albumin human, USP Injection 1741289
    • Albumin human-kjda Injection 2645873
    • Albumin human, USP Injectable Product 1154314
    • Albumin human-kjda Injectable Product 2660622
    • Albumin human, USP Injection [Albuminex] 2054162
    • Albumin human-kjda Injection [Albuminex] 2657914
    • Albuminex Injectable Product 2054163
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 500 ML albumin human-kjda 50 MG/ML Injection SCD · 2054226
  • Albumin human-kjda 50 MG/ML SCDC · 2054220
  • Albumin human, USP Injection SCDF · 1741289
  • Albumin human-kjda Injection SCDFP · 2645873
  • Albumin human, USP Injectable Product SCDG · 1154314
  • Albumin human-kjda Injectable Product SCDGP · 2660622

Brand-Name Concepts

  • Albumin human-kjda 50 MG/ML [Albuminex] SBDC · 2054222
  • Albumin human, USP Injection [Albuminex] SBDF · 2054162
  • Albumin human-kjda Injection [Albuminex] SBDFP · 2657914
  • Albuminex Injectable Product SBDG · 2054163
  • Albuminex BN · 2054160

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2054227 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64208-2510-01 1 VIAL, GLASS in 1 CARTON (64208-2510-1) / 250 mL in 1 VIAL... ALBUMINEX BPL 2020-05-27
64208-2510-05 1 VIAL, GLASS in 1 CARTON (64208-2510-5) / 500 mL in 1 VIAL... ALBUMINEX BPL 2020-05-27
Observed labelers: BPL (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.